Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
The FDA subsequently classified AOD-9604 within Category 2 of the bulk drug substance review process, and the compound was later withdrawn from that nomination in April 2026
Skip it, and one of those lines gets denied automatically
No dose-ranging studies have established safety margins, optimal administration routes, or duration of treatment
A 2018 study found 5-amino-1MQ increased NAD+ by up to 40% in cultured adipocytes, but this cellular change precedes noticeable effects by weeks
Athletes subject to WADA, USADA, NCAA, or other anti-doping testing should not use BPC-157
Youll need regular check-ups and blood tests to see if the treatment is working
US$ 20.87
US$ 22.23
US$ 20.86
US$ 23.83
US$ 22.32
